Enochian Biosciences Announces FDA INTERACT Meeting for a Potential Cure for HIV

NEXT STORY
Chimerix Appoints Pratik S. Multani, M.D., to Board of Directors
PREV STORY
ContraFect Announces U.S. FDA Grants Breakthrough Therapy Designation to Exebacase for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia, Including Right-Sided Endocarditis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clinical Genomics Presents Data Supporting Novel 2-Gene Blood Test for Earlier Detection of Colorectal Cancer Recurrence at ASCO GI

EDISON, N.J., Jan. 25, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing ...

author_avatar
NASDAQ Market News

Aptevo Therapeutics to Present at the 29th Annual ROTH Conference

SEATTLE, March 06, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company ...

author_avatar
NASDAQ Market News

CytomX Therapeutics Appoints Charles S. Fuchs, M.D., MPH to Board of Directors

SAN FRANCISCO, Oct. 24, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical ...

author_avatar
NASDAQ Market News